Why Addus HomeCare Stock Is On Investors’ Radar

Addus HomeCare (ADUS) has drawn attention after recent trading leaves the stock with a market value of about US$1.8b and a latest closing price of US$100.12 per share.

With year-to-date and 1-year total returns both in negative territory, yet a 3-year total return close to 20%, investors are weighing how the company’s current valuation lines up with its financial profile.

See our latest analysis for Addus HomeCare.

The recent 9.31% 1 month share price return, alongside a year to date share price decline of 6.06% and a 3 year total shareholder return of 19.69%, suggests near term momentum is improving while longer term performance has been more moderate.

If this mix of short term recovery and longer term resilience interests you, it can be useful to see what else is moving and compare against 17 top founder-led companies

With Addus trading around US$100.12, a market value near US$1.8b and indications of a possible intrinsic discount, the key question is simple: is this a buying opportunity or is the market already pricing in future growth?

Most Popular Narrative: 9% Undervalued

At a last close of $100.12 versus a narrative fair value of $110.03, the most followed story on Addus frames the stock as modestly mispriced, hinging on measured revenue growth, firmer margins and a steady discount rate of 6.98%.

The looming threat of significant government healthcare spending cuts to address federal budget deficits could reduce funding for Medicaid and Medicare programs, which are critical revenue streams for Addus HomeCare. This would directly pressure revenue and earnings, especially as provisions of the reconciliation bill begin to impact state budgets in 2028.

Read the complete narrative.

Curious how a cautious view on growth, firmer margins and a slightly lower future P/E still supports upside from here? The full narrative lays out the earnings path and valuation bridge that underpin that $110.03 fair value call.

Result: Fair Value of $110.03 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you also need to factor in risks such as potential Medicaid funding cuts and rising labor costs, which could pressure margins and challenge the view that the stock is underpriced.

Find out about the key risks to this Addus HomeCare narrative.

Next Steps

If the mix of potential upside and clear risks feels balanced, it may be worth checking the numbers yourself and forming a view before the market moves; a helpful place to start is by reviewing the 5 key rewards

Looking For More Investment Ideas?

Before you move on, give yourself the chance to uncover a few more angles that could complement or contrast with what you have seen here.

• Spot potential value candidates early by checking stocks that currently screen as 48 high quality undervalued stocks based on their fundamentals.
• Build a portfolio with staying power by reviewing companies in the solid balance sheet and fundamentals stocks screener (44 results) that may handle pressure better than most.
• Add a few off-the-radar opportunities to your watchlist by scanning the screener containing 25 high quality undiscovered gems before others start paying attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.